Key result
Multimodality imaging, including echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging, plays a complementary role in the evaluation and management of hypertrophic cardiomyopathy.
Why the study?
Diagnosis and management of hypertrophic cardiomyopathy requires accurate, comprehensive imaging to characterize phenotype, assess risk, monitor progression, and guide therapy.
This review highlights the complementary roles of multimodality imaging in the evaluation and management of hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May guide imaging selection in HCM; leaves open prospective validation of protocols.
The diagnosis and management of hypertrophic cardiomyopathy (HCM) requires accurate and comprehensive imaging. Advances in imaging technology and clinical understanding have significantly enhanced the ability to characterize the phenotype, assess risk, monitor disease progression, and guide therapy. This article highlights the complementary roles of echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging in the evaluation of HCM and explores emerging research and innovation that are shaping future diagnostic and therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Peters et al. (2026) conducted a review in Hypertrophic cardiomyopathy. Multimodality imaging was evaluated. Multimodality imaging, including echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging, plays a complementary role in the evaluation and management of hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: